Identifying targets for these treatments involves a combination of epidemiological studies, molecular biology, and genomics. Researchers use data from population studies to identify genetic variations associated with diseases. Techniques like genome-wide association studies (GWAS) and next-generation sequencing (NGS) are instrumental in pinpointing specific genes or proteins that can be targeted. Additionally, bioinformatics tools help in predicting the impact of these targets on disease progression.
